Status:
COMPLETED
Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborating Sponsors:
Janssen Pharmaceutica N.V., Belgium
Conditions:
Schizophrenia
Schizoaffective
Eligibility:
All Genders
18-55 years
Brief Summary
The purpose of this study is to prospectively examine adherence to oral atypical antipsychotics in patients with schizophrenia. We are psrticularly interested in examining the level of agreement among...
Detailed Description
Fifty schizophrenia patients will be recruited at the time of their clinic visit to Tri-County MHMR Services and the El Paso Community MHMR Center. Both physicians and patients will be asked to rate t...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosis of Schizophrenia or Schizoaffective disorder
- Between the ages of 18-55
- no documented history of head injury, mental retardation or neurological disorder
Exclusion
Key Trial Info
Start Date :
April 1 2004
Trial Type :
OBSERVATIONAL
End Date :
March 1 2005
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00223522
Start Date
April 1 2004
End Date
March 1 2005
Last Update
September 22 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UTHSCSA
San Antonio, Texas, United States, 78229